Search
for
Sort by
Research 271–300 of 1000+
- DESENVOLVIMENTO BIOTECNOLÓGICO DE SÉRUM REJUVENESCEDOR ANTIOXIDANTE CONTENDO ATIVO LIPÍDICO ORIUNDO DA RANA CATESBEIANA SHAW
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- Melatonin membrane receptors in peripheral tissues: Distribution and functions
- Developmental origin of polycystic ovary syndrome - a hypothesis
- Is dehydroepiandrosterone a hormone?
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology
- Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin
- Obesity and polycystic ovary syndrome
- Safety of testosterone treatment in postmenopausal women
- PCOS in adolescents
- Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility
- Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome
- Assessment of the obese patient
- Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
- Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients
- Polycystic ovary syndrome (PCOS)
- Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
- Cardiovascular risk factors and events in women with androgen excess
- Gender-Affirming Hormone Therapy for Transgender Men
- Androgen treatment of postmenopausal women
- Polycystic ovary syndrome is associated with atherogenic changes in lipoprotein particle number and size independent of body weight
- Obesity and the Polycystic Ovary Syndrome
- Current Perspectives on the Physiological Activities of Fermented Soybean-Derived Cheonggukjang
- Hormonal and Surgical Treatment Options for Transgender Men (Female-to-Male)
- Cross-sex hormone therapy for gender dysphoria
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- The Use of Adipose-Derived Stem Cells in Selected Skin Diseases (Vitiligo, Alopecia, and Nonhealing Wounds)